CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity
Author:
Funder
Aventis Pharmaceuticals
OSI, Inc.
NIH
PNW Prostate SPORE
Publisher
Wiley
Subject
Urology,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.21077/fullpdf
Reference37 articles.
1. Drug insight: Use of docetaxel in prostate and urothelial cancers;Mackler;Nat Clin Pract Urol,2005
2. Advances in prostate cancer chemotherapy: A new era begins;Pienta;CA Cancer J Clin,2005
3. Docetaxel (taxotere) in the treatment of prostate cancer;Beer;Expert Rev Anticancer Ther,2003
4. Neoadjuvant mitoxantrone and docetaxel for high-risk localized prostate cancer;Garzotto;Urol Oncol,2006
5. Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: Identification of a cytoprotective mechanism involving growth differentiation factor 15;Huang;Clin Cancer Res,2007
Cited by 97 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. PD-1 inhibitor combined with Docetaxel exerts synergistic anti-prostate cancer effect in mice by down-regulating the expression of PI3K/AKT/NFKB-P65/PD-L1 signaling pathway;Cancer Biomarkers;2024-05-28
2. Insights into molecular mechanisms of chemotherapy resistance in cancer;Translational Oncology;2024-04
3. Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia;Clinical Cancer Research;2024-03-07
4. Genomic Discoveries: Precision Medicine and Personalized Approaches in Prostate Cancer Care;Transforming Prostate Cancer Care;2024
5. Chemotactic signaling pathways in prostate cancer: Implications in the tumor microenvironment and as potential therapeutic targets;International Review of Cell and Molecular Biology;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3